DPCM Capital, Inc.

NYSE:XPOA Stock Report

Market Cap: US$324.8m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

DPCM Capital Valuation

Is XPOA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of XPOA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate XPOA's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate XPOA's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for XPOA?

Key metric: As XPOA is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for XPOA. This is calculated by dividing XPOA's market cap by their current earnings.
What is XPOA's PE Ratio?
PE Ratio59.9x
EarningsUS$5.42m
Market CapUS$324.75m

Price to Earnings Ratio vs Peers

How does XPOA's PE Ratio compare to its peers?

The above table shows the PE ratio for XPOA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average36.4x
SLVR SILVERspac
30.9xn/aUS$327.5m
AFTR AfterNext HealthTech Acquisition
92.8xn/aUS$325.3m
JGGC Jaguar Global Growth Corporation I
9.4xn/aUS$217.4m
SVII Spring Valley Acquisition II
12.5xn/aUS$110.8m
XPOA DPCM Capital
59.9xn/aUS$324.8m

Price-To-Earnings vs Peers: XPOA is expensive based on its Price-To-Earnings Ratio (59.9x) compared to the peer average (49.1x).

Price to Earnings Ratio vs Industry

How does XPOA's PE Ratio compare vs other companies in the US Capital Markets Industry?

23 CompaniesPrice / EarningsEstimated GrowthMarket Cap
ADX Adams Diversified Equity Fund
3.6xn/aUS$2.27b
CET Central Securities
4.5xn/aUS$1.33b
GAM General American Investors Company
4.2xn/aUS$1.19b
MUDS Mudrick Capital Acquisition Corporation II
3.4xn/aUS$401.64m
XPOA 59.9xIndustry Avg. 23.2xNo. of Companies73PE020406080100+
23 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: XPOA is expensive based on its Price-To-Earnings Ratio (59.9x) compared to the US Capital Markets industry average (30.7x)

Price to Earnings Ratio vs Fair Ratio

What is XPOA's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

XPOA PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio59.9x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate XPOA's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst XPOA forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
Nov ’25n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
Oct ’25n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
Sep ’25n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
Aug ’25n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
Jul ’25n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
Jun ’25n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
May ’25n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
Apr ’25n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
Mar ’25n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
Feb ’25n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
Jan ’25n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
Dec ’24n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
Nov ’24n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
Oct ’24n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
Sep ’24n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
Aug ’24n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
Jul ’24n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
Jun ’24n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
May ’24n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
Apr ’24n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
Mar ’24n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
Feb ’24n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
Jan ’24n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
Dec ’23n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2
Nov ’23n/a
US$13.50
0%
3.7%US$14.00US$13.00n/a2

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.

Discover undervalued companies

International Money Express

US$656.2m

Operates as an omnichannel money remittance services company in the United States, Latin America, Mexico, Central and South America, the Caribbean, Africa, and Asia.

IMXI

US$21.10

7D

-1.0%

1Y

0.5%

VEF

SEK 2.2b

A venture capital firm specializing in early venture, emerging growth and growth capital investments.

VEFF.F

SEK 0.20

7D

0%

1Y

n/a

Federal Home Loan Mortgage

US$10.1b

Operates in the secondary mortgage market in the United States.

FMCC

US$3.13

7D

1.0%

1Y

374.2%